Squarepoint Ops LLC Buys Shares of 9,686 Masimo Co. (NASDAQ:MASI)

Squarepoint Ops LLC purchased a new stake in shares of Masimo Co. (NASDAQ:MASI - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 9,686 shares of the medical equipment provider's stock, valued at approximately $1,220,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MASI. Edgestream Partners L.P. purchased a new position in shares of Masimo in the 2nd quarter valued at $645,000. Simplify Asset Management Inc. raised its position in Masimo by 120.4% in the second quarter. Simplify Asset Management Inc. now owns 21,670 shares of the medical equipment provider's stock valued at $2,729,000 after purchasing an additional 11,838 shares during the period. State Board of Administration of Florida Retirement System lifted its stake in shares of Masimo by 11.6% during the first quarter. State Board of Administration of Florida Retirement System now owns 54,839 shares of the medical equipment provider's stock worth $8,053,000 after purchasing an additional 5,688 shares in the last quarter. Advisors Asset Management Inc. boosted its position in shares of Masimo by 32.1% in the first quarter. Advisors Asset Management Inc. now owns 9,009 shares of the medical equipment provider's stock worth $1,323,000 after buying an additional 2,187 shares during the period. Finally, Vanguard Group Inc. grew its stake in shares of Masimo by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 4,781,343 shares of the medical equipment provider's stock valued at $560,421,000 after buying an additional 26,473 shares in the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Needham & Company LLC restated a "hold" rating on shares of Masimo in a report on Friday, September 20th. Piper Sandler upped their target price on shares of Masimo from $160.00 to $165.00 and gave the company an "overweight" rating in a research note on Wednesday, August 7th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Masimo presently has a consensus rating of "Moderate Buy" and a consensus price target of $144.67.

Masimo Stock Up 4.8 %

MASI traded up $6.41 during trading on Friday, hitting $138.83. The company had a trading volume of 2,475,413 shares, compared to its average volume of 675,481. Masimo Co. has a 1-year low of $75.22 and a 1-year high of $153.93. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. The company has a market cap of $7.38 billion, a PE ratio of 94.44 and a beta of 0.99. The business has a 50-day moving average of $119.78 and a 200-day moving average of $125.02.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, topping the consensus estimate of $0.77 by $0.09. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The business had revenue of $496.30 million for the quarter, compared to analysts' expectations of $493.92 million. During the same quarter last year, the company posted $0.62 earnings per share. The company's quarterly revenue was up 9.0% compared to the same quarter last year. As a group, analysts forecast that Masimo Co. will post 3.87 earnings per share for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.